Cargando…

354. The Epidemiology and Clinical Features of Acanthamoeba Disease in the United States, 1956–2018

BACKGROUND: Acanthamoeba is a free-living ameba found worldwide in soil and water that can cause severe illness. Transmission is thought to be through the skin, eyes, or lungs; Acanthamoeba can cause disseminated infection (Acanthamoeba disease) in addition to the more widely recognized Acanthamoeba...

Descripción completa

Detalles Bibliográficos
Autores principales:	O’Laughlin, Kevin, Cope, Jennifer R, Marsh, Zachary A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777154/ http://dx.doi.org/10.1093/ofid/ofaa439.549

Ejemplares similares

The Epidemiology and Clinical Features of Non-Keratitis Acanthamoeba Infections in the United States, 1956–2020
por: Haston, Julia C, et al.
Publicado: (2023)

130. increase in Multidrug Resistance (2011–2018) and the Emergence of Extensive Drug Resistance (2020) in shigella Sonnei in the United States
por: Logan, Naeemah Z, et al.
Publicado: (2020)

1675. Epidemiology of Urinary Tract Infections in the United States, 2009 - 2018
por: Foster, Kendra, et al.
Publicado: (2020)

354. Evidence of Aspergillosis Among Patients With Influenza-Associated Hospitalizations—United States, 2005–2017
por: Toda, Mitsuru, et al.
Publicado: (2018)

865. Acanthamoeba Disease Associated With the Practice of Nasal Rinsing in Immunocompromised Patients
por: Cope, Jennifer, et al.
Publicado: (2018)

TME5/354: A Videoconference System for Telepathology
por: de Cabo, M, et al.
Publicado: (1999)

1254. Molecular Epidemiology of Escherichia coli Causing Urinary Tract Infections in United States and in vitro Activity of Tebipenem, Including Against Strain Lineage and Resistant subsets (2018-2020)
por: Mendes, Rodrigo E, et al.
Publicado: (2021)

35.4 A PUBLIC HEALTH APPROACH TO THE PREVENTION OF PSYCHOSIS
por: Murray, Robin, et al.
Publicado: (2018)

1609. Epidemiology and Susceptibility to Imipenem/Relebactam of Gram-Negative Pathogens from Patients with Lower Respiratory Tract Infections – SMART United States 2017-2018
por: Lob, Sibylle, et al.
Publicado: (2020)

354. SARS-CoV-2 Viral Viability Culture and Sequencing from Immunocompromised Patients with Persistently Positive SARS-CoV-2 PCR Results
por: Sung, Abby, et al.
Publicado: (2021)

1420. Descriptive Epidemiology of UTI Hospitalizations in the US, 2018
por: Zilberberg, Marya, et al.
Publicado: (2021)

132. Emergence and Spread of Multidrug-resistant salmonella Serotype Infantis Infections in the United States, 2003–2018
por: Medalla, Felicita, et al.
Publicado: (2020)

PM354. The effects of visual cues on for the ultimatum game in persons with autism spectrum disorders
por: Ikuse, Daisuke, et al.
Publicado: (2016)

Professor Ogobara K. Doumbo (1956–June 9, 2018)
por: Djimdé, Abdoulaye, et al.
Publicado: (2018)

Prof Amela Kulenovic, MD, PhD (1956-2018)
por: Masic, Izet
Publicado: (2019)

354 Six Months of Surveillance for Carbapenem-Resistant Enterobacteriaceae in Maryland
por: Vaeth, Elisabeth, et al.
Publicado: (2014)

Contributions of Member States for the Year 1956
por: European Organization for Nuclear Research
Publicado: (1956)

765. Epidemiological And Clinical Features Of Rickettsiosis
por: Hammami, Fatma, et al.
Publicado: (2020)

1428. Lyme Disease Treatment in the United States: Prescribing Patterns from a Nationwide Commercial Insurance Database, 2016-2018
por: Beeson, Amy M, et al.
Publicado: (2020)

48. Clinical Characteristics of Acute Flaccid Myelitis Cases Associated with Enteroviruses D68 and A71 — United States, 2018
por: Kidd, Sarah, et al.
Publicado: (2020)

863. Pre-Exposure Prophylaxis (PrEP) Prescriptions among Individuals at High Risk for HIV in the United States, 2012-2018
por: Zhou, Mo, et al.
Publicado: (2021)

1956 : novela
por: Rosenzweig, Carmen, 1925-
Publicado: (1958)

1956. Reduction in Endotracheal Aspirate Cultures after Implementation of a Diagnostic Stewardship Intervention in a Pediatric Intensive Care Unit
por: Sick-Samuels, Anna, et al.
Publicado: (2019)

1587. Activity of Ceftolozane/Tazobactam against Gram-Negative Isolates from Lower Respiratory Tract Infections – SMART United States 2018
por: Lob, Sibylle, et al.
Publicado: (2020)

1388. Epidemiology and Treatment Outcomes of Nontuberculous Mycobacterial Infections at a Community Teaching Hospital in the Southeastern United States
por: Vivian Tsai, Y, et al.
Publicado: (2021)

666. Molecular Epidemiology of Methicillin-Resistant Staphylococcus aureus in Chile between 1999-2018
por: Martínez, Jose R W, et al.
Publicado: (2021)

1430. Descriptive Epidemiology of Emergency Department Visits with cUTI in the US, 2012-2018
por: Zilberberg, Marya, et al.
Publicado: (2021)

1584. In Vitro Activity of Imipenem/Relebactam against Gram-Negative Pathogens from Patients with Bloodstream Infections in the United States and Canada – SMART 2018
por: Lob, Sibylle, et al.
Publicado: (2020)

714. Increase in Multidrug-resistant Salmonella Serotype I 4,[5],12:i:- Infections Linked to Pork—United States, 2009–2018
por: Plumb, Ian D, et al.
Publicado: (2020)

1229. Antimicrobial Activity of Plazomicin against Multidrug-resistant Enterobacterales: Results from 3 Years of Surveillance in Hospitals in the United States (2018–2020)
por: Carvalhaes, Cecilia G, et al.
Publicado: (2021)

Contributions of the Member States for the Financial Year 1956
Publicado: (1956)

Contributions of Member States for the Financial Year 1956
Publicado: (1956)

Contributions of Member States for the Financial Year 1956
Publicado: (1956)

Contributions of the Member States for the Financial Year 1956
Publicado: (1956)

1673. Epidemiology of Complicated Urinary Tract Infections (cUTIs) Presenting in Emergency Departments Across the United States (US)
por: Lodise, Thomas, et al.
Publicado: (2020)

Report: 1956
por: National Bureau of Standards. Washington, DC, et al.
Publicado: (1957)

1887. Estimating the Burden of Waterborne Disease in the United States
por: Collier, Sarah, et al.
Publicado: (2019)

1236. Update on the In Vitro Activity of Ceftaroline against Staphylococcus aureus from United States (US) Medical Centers Stratified by Infection Type (2018-2020)
por: Sader, Helio S, et al.
Publicado: (2021)

870. Coverage, Cost Sharing, and Out-of-Pocket Costs for Single-Tablet HIV Antiretroviral Regimens in Qualified Health Plans in the United States, 2018-2020
por: Khazanchi, Rohan, et al.
Publicado: (2021)

1455. Epidemiology, Empiric Treatment, and Outcomes Among Hospitalized Patients With Complicated Urinary Tract Infections in the United States, 2013–2018
por: Zilberberg, Marya, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_6aejjktbkqp79099oc1pdft2pg